Navigation Links
Cancer Patients Can Benefit From Early Detection Of Heart Damage Using Echocardiography
Date:10/6/2011

MORRISVILLE, N.C., Oct. 6, 2011 /PRNewswire-USNewswire/ -- There is good news for cancer patients whose medical treatments put them at risk for future cardiac problems: using strain echocardiography can help physicians detect early signs of cardiac toxicity.  To help get this information out to those in need, the American Society of Echocardiography (ASE) is preparing a guideline document outlining the best way to evaluate cancer patients, and has funded a research study to enhance identification of patients who are at risk.

The September 2011 death of 51-year-old Kara Kennedy of a heart attack brought the link between cancer treatments and cardiovascular damage into the spotlight for both patients and their physicians. Kennedy, the only daughter of Senator Edward M. Kennedy, was reportedly in remission after having been treated for lung cancer in 2002. While the direct relationship between her cancer treatment and her death remain unclear, one theory links damage to her heart from her chemo treatments.  With this tragedy, physician awareness of the link between specific cancer therapies and heart complications has renewed interest.

In the past, when cancer treatments were not very effective and cancer was usually fatal, little attention was paid to the complications from treatment.  With the advent of more successful new therapies for cancer that have raised survival rates, concerns about their long-term effects have now become paramount. "There are 2.2 million survivors of breast cancer in the U.S. alone," said Juan Carlos Plana, MD, Co-director of Cardio-oncology, Cleveland Clinic, "and heart disease, not cancer, is the biggest risk they face." When a patient is diagnosed with breast cancer, she (or he) is tested for the HER2 mutation, an aggressive form of cancer which affects 20-25% of breast cancer patients and is typically treated with Doxorubicin, followed by Herceptin. Unfortunately, as many as one third of patients receiving these two drugs will develop cardiotoxicity, and some will progress to full-blown heart failure, which means they could potentially need mechanical devices or heart transplants in order to survive.  

The advent of strain echocardiography for early identification of cardiac problems is great news for those suffering from many forms of cancer. "The goal is not to stop cancer therapy, but to identify cardiotoxicity early and to protect the heart with medications so heart failure does not become a problem and the cancer treatment can be continued," Dr. Plana explained. "Currently, 17% of patients receiving treatment for the most aggressive form of breast cancer have to stop therapy due to heart issues. The sensitivity of strain echo allows early detection so oncologists can treat their patients without fear of the downstream effects of the therapies."

Dr. Plana, who is a Fellow of the American Society of Echocardiography and served as medical director of cardiac imaging at Houston's MD Anderson Cancer Center, now heads a newly-formed cardio-oncology center at the Cleveland Clinic, where every patient slated for a cancer therapy with the potential for toxicity receives an intensive left-ventricular mechanics protocol, which includes both 3D echocardiography with contrast and strain imaging.

To highlight the benefits of these screenings, ASE has collaborated with the European Association of Echocardiography and the American Society of Clinical Oncology to organize a guideline writing group, led by Dr. Plana.  A previous paper  entitled "Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients," written with ASE Board of Directors member Marielle Scherrer-Crosbie, MD, PhD, FASE, MCH, Associate Professor of Medicine, Massachusetts General Hospital and Harvard Medical School, and others for the American Journal of Cardiology, has already outlined exciting progress in this area.

ASE expects its new guideline to be available in 2012. To take the new clinical application for echocardiography one step further, the ASE Education and Research Foundation has also funded a Career Development Award on the use of strain and 3D echocardiography to identify patients who are at high risk for developing heart complications even before they start chemotherapy treatment. The lead researcher, ASE member Timothy Tan, MBBS, PhD, Clinical and Research Fellow, Massachusetts General Hospital and Harvard Medical School, hopes the research "will increase the understanding of heart failure associated with cancer treatment, potentially helping to decrease its morbidity and mortality."

As the largest global organization for cardiovascular ultrasound imaging, the American Society of Echocardiography (ASE) is the leader and advocate, setting practice standards and guidelines.  Comprised of over 15,000 physicians, sonographers, nurses and scientists, ASE is a strong voice providing guidance, expertise and education to its members with a commitment to improving the practice of ultrasound and imaging of the heart and cardiovascular system for better patient outcomes. Full text of ASE's guidelines is available at http://www.asecho.org/guidelines.  For more information about ASE, visit www.asecho.org or ASE's public information site, www.SeeMyHeart.org.

CONTACT:
Cathy Kerr (919) 297-7156
ckerr@asecho.org or
Andrea Van Hoever (919) 297-7163
avanhoever@asecho.org


'/>"/>
SOURCE American Society of Echocardiography
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Novel Technology Breaks Through Cancer Pain
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... 27, 2016 Elekta today announced ... will be the focal point of seven scientific presentations ... Society for Radiotherapy & Oncology, taking place April 29 ... state-of-the-art radiotherapy system and a high-field MRI scanner with ... the patient,s anatomy in real time. The MR-linac is ...
(Date:4/27/2016)... , April 27, 2016  Bayer Animal Health ... senior from the University of Florida College of ... Bayer Excellence in Communication Award (BECA). Brittany was ... were awarded a total of $70,000 in scholarship ... four years, Bayer has provided a total of ...
(Date:4/27/2016)... , April 27, 2016 ... USD 2.14 billion by 2022, according to a ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , ... affecting the efficiency and accuracy delivered by the ... demand for novel urinalysis instruments and consumables. For ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... 29, 2016 , ... Regenerative Medicine Solutions (RMS) scored 94.8124 out ... earning them second place for Tampa’s Best Places to Work. They were ranked in ... a great accomplishment for our team,” says RMS Human Resources Manager Irene Miller. “We ...
(Date:4/29/2016)... San Rafael, CA (PRWEB) , ... April 29, 2016 , ... ... a week long softball camp from July 24th – 27th for girls aged 10-18. ... The camp is held at the beautiful Clark V. Whited Complex, one of the ...
(Date:4/29/2016)... ... 29, 2016 , ... HEALTHCAREfirst , the leading provider ... Deyta Analytics, recently announced the recipients of the fourth annual Hospice Honors, a ... from the caregiver’s point of view. The official list of recipients was unveiled ...
(Date:4/29/2016)... ... April 29, 2016 , ... Intellitec ... held May 16th to 18th at the Broward County Convention Center. The event ... to collaborate on best practices in public facility management. Intellitec Solutions will highlight ...
(Date:4/29/2016)... ... April 29, 2016 , ... Yisrayl Hawkins, Pastor and ... highlighting inconsistencies of adding BC and AD, saying it is time to set the ... After Christ. Yisrayl says this simply cannot possibly be true and offers explanation. , ...
Breaking Medicine News(10 mins):